453 Results

People

  1. Kelsen
    Kelsen
  2. Motzer
    Motzer
  3. Kris
    Kris
  4. Saltz
    Saltz
  5. Abrey
    Abrey
  6. O'Reilly
    O'Reilly
  7. Schwartz
    Schwartz
  8. Hudis
    Hudis
  9. Aghajanian
    Aghajanian
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)
  7. Center for Hematologic Malignancies (63)
  8. Epidemiology and Biostatistics (61)
  9. Biostatistics Service (60)
  10. Genitourinary Oncology Service (59)
  1. "leukopenia"
Formats
  1. Journal Article (435)
  2. Review (9)
  3. Conference Paper (4)
  4. Editorial (2)
  5. Research Letter (2)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)

More Groups

People
  1. David Kelsen (33)
  2. Robert Motzer (29)
  3. Mark Kris (25)
  4. Leonard Saltz (21)
  5. Eileen O'Reilly (18)
  6. Lauren Abrey (18)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Cancer (33)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (15)
  5. Gynecologic Oncology (14)
  6. Investigational New Drugs (14)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Springer (52)
  3. American Society of Clinical Oncology (43)
  4. Wiley Blackwell (39)
  5. American Association for Cancer Research (36)
  6. Oxford University Press (33)

More Publishers

Results (453)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer
    Journal Article

    Rizvi, N. A.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M. J.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Chemoradiation for unresectable stage III non-small cell lung cancer
    Journal Article

    Price, K. A. R.; Azzoli, C. G.; Gaspar, L. E.
    Seminars in Thoracic and Cardiovascular Surgery (2008)

    Fulltext@MSK | Save
  • Azacitidine and the beginnings of therapeutic epigenetic modulation
    Journal Article

    O'dwyer, K.; Maslak, P.
    Expert Opinion on Pharmacotherapy (2008)

    Fulltext@MSK | Save
  • A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma
    Journal Article

    O'Connor, O. A.; Portlock, C.; Moskowitz, C.; Straus, D.; Hamlin, P.; Stubblefield, M.; Dumitrescu, O.; Colevas, A. D.; Grant, B.; Zelenetz, A.
    British Journal of Haematology (2008)

    Fulltext@MSK | Save
  • Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
    Journal Article

    Motzer, R. J.; Escudier, B.; Oudard, S.; Hutson, T. E.; Porta, C.; Bracarda, S.; Grünwald, V.; Thompson, J. A.; Figlin, R. A.; Hollaender, N.; more...
    Lancet (2008)

    Fulltext@MSK | Save
  • Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Motzer, R. J.
    Clinical Genitourinary Cancer (2008)

    Fulltext@MSK | Save
  • Overview of lymphoma diagnosis and management
    Journal Article

    Matasar, M. J.; Zelenetz, A. D.
    Radiologic Clinics of North America (2008)

    Fulltext@MSK | Save
  • Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel
    Journal Article

    Liu, M. C.; Demetri, G. D.; Berry, D. A.; Norton, L.; Broadwater, G.; Robert, N. J.; Duggan, D.; Hayes, D. F.; Henderson, I. C.; Lyss, A.; more...
    Cancer Treatment Reviews (2008)

    Fulltext@MSK | Save
  • Anticancer drug therapy in the older cancer patient: Pharmacology and polypharmacy
    Journal Article

    Lichtman, S. M.; Boparai, M. K.
    Current Treatment Options in Oncology (2008)

    Fulltext@MSK | Save
  • Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma
    Journal Article

    Leonard, J. P.; Gregory, S. A.; Maloney, D. G.; Vose, J. M.; Younes, A.; Zelenetz, A. D.
    Clinical Advances in Hematology & Oncology (2008)

    Fulltext@MSK | Save